These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 32303308)

  • 1. What Do We Know About Clodronate Now? A Medical and Veterinary Perspective.
    Markell R; Saviola G; Barker EA; Conway JD; Dujardin C
    J Equine Vet Sci; 2020 May; 88():102874. PubMed ID: 32303308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of bisphosphonates in horses - a review].
    Düsterdieck-Zellmer KF
    Tierarztl Prax Ausg G Grosstiere Nutztiere; 2018 Oct; 46(5):323-333. PubMed ID: 30340242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy of clodronic acid in horses diagnosed with navicular syndrome: A field study using objective and subjective lameness evaluation.
    Argüelles D; Saitua A; de Medina AS; Muñoz JA; Muñoz A
    Res Vet Sci; 2019 Aug; 125():298-304. PubMed ID: 31351199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clodronate improves lameness in horses without changing bone turnover markers.
    Mitchell A; Wright G; Sampson SN; Martin M; Cummings K; Gaddy D; Watts AE
    Equine Vet J; 2019 May; 51(3):356-363. PubMed ID: 30153345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tiludronate and clodronate do not affect bone structure or remodeling kinetics over a 60 day randomized trial.
    Richbourg HA; Mitchell CF; Gillett AN; McNulty MA
    BMC Vet Res; 2018 Mar; 14(1):105. PubMed ID: 29554967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of clodronate in the management of osteoarthritis: an update.
    Saviola G; Abdi-Ali L; Comini L; Dalle-Carbonare LG
    J Biol Regul Homeost Agents; 2019 September-October,; 33(5):1315-1320. PubMed ID: 31591875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Necrotic actions of nitrogen-containing bisphosphonates and their inhibition by clodronate, a non-nitrogen-containing bisphosphonate in mice: potential for utilization of clodronate as a combination drug with a nitrogen-containing bisphosphonate.
    Oizumi T; Yamaguchi K; Funayama H; Kuroishi T; Kawamura H; Sugawara S; Endo Y
    Basic Clin Pharmacol Toxicol; 2009 May; 104(5):384-92. PubMed ID: 19413658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clodronate and other bisphosphonates as supportive therapy in osteolysis due to malignancy.
    Elomaa I; Blomqvist C
    Acta Oncol; 1995; 34(5):629-36. PubMed ID: 7546830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of action of bisphosphonates.
    Reszka AA; Rodan GA
    Curr Osteoporos Rep; 2003 Sep; 1(2):45-52. PubMed ID: 16036064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and residence time of bisphosphonates in bone of horses.
    Knych HK; Janes J; Kennedy L; McKemie DS; Arthur RM; Samol MA; Uzal FA; Scollay M
    J Vet Diagn Invest; 2022 Jan; 34(1):23-27. PubMed ID: 34918585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Basic Studies on the Mechanism, Prevention, and Treatment of Osteonecrosis of the Jaw Induced by Bisphosphonates].
    Endo Y; Funayama H; Yamaguchi K; Monma Y; Yu Z; Deng X; Oizumi T; Shikama Y; Tanaka Y; Okada S; Kim S; Kiyama T; Bando K; Shima K; Suzuki H; Takahashi T
    Yakugaku Zasshi; 2020; 140(1):63-79. PubMed ID: 31902887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonistic effects of different classes of bisphosphonates in osteoclasts and macrophages in vitro.
    Frith JC; Rogers MJ
    J Bone Miner Res; 2003 Feb; 18(2):204-12. PubMed ID: 12568397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid chromatography-mass spectrometry analysis of five bisphosphonates in equine urine and plasma.
    Wong AS; Ho EN; Wan TS; Lam KK; Stewart BD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Aug; 998-999():1-7. PubMed ID: 26143477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonates in the prevention of bone metastases: current evidence.
    Diel IJ
    Semin Oncol; 2001 Aug; 28(4 Suppl 11):75-80. PubMed ID: 11544581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of I.V. Nonnitrogen bisphosphonates on the occurrence of osteonecrosis of the jaw: long-term follow-up on prostate cancer patients.
    Rodrigues P; Hering F; Imperio M
    Clin Genitourin Cancer; 2015 Jun; 13(3):199-203. PubMed ID: 25475039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonates in multiple myeloma: a network meta-analysis.
    Mhaskar R; Redzepovic J; Wheatley K; Clark OA; Miladinovic B; Glasmacher A; Kumar A; Djulbegovic B
    Cochrane Database Syst Rev; 2012 May; (5):CD003188. PubMed ID: 22592688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of the Mechanism of Action and Use of Bisphosphonates in Horses.
    Yocom A; Contino E; Kawcak C
    J Equine Vet Sci; 2023 Aug; 127():104503. PubMed ID: 37120118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrasting effects of alendronate and clodronate on RAW 264 macrophages: the role of a bisphosphonate metabolite.
    Makkonen N; Salminen A; Rogers MJ; Frith JC; Urtti A; Azhayeva E; Mönkkönen J
    Eur J Pharm Sci; 1999 May; 8(2):109-18. PubMed ID: 10210733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injectable bisphosphonates in the treatment of postmenopausal osteoporosis.
    Sartori L; Adami S; Filipponi P; Crepaldi G
    Aging Clin Exp Res; 2003 Aug; 15(4):271-83. PubMed ID: 14661816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonates: preclinical aspects and use in osteoporosis.
    Fleisch HA
    Ann Med; 1997 Feb; 29(1):55-62. PubMed ID: 9073324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.